SFX by Ex Libris Inc.

Title:	Structural and molecular basis for Ebola virus neutralization by protective human antibodies
Source:	Science [0036-8075] Misasi, J yr:2016

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Robeson, L.M. M. "Correlation of separation factor versus permeability for polymeric membranes." Journal of membrane science 62.2 (1991): 165-185.
description	2.	Trück, J. "Identification of Antigen-Specific B Cell Receptor Sequences Using Public Repertoire Analysis." The journal of immunology 194.1 (2014): 252-261.
description	3.	Murin, Charles D. "Structures of protective antibodies reveal sites of vulnerability on Ebola virus." Proceedings of the National Academy of Sciences of the United States of America 111.48 (2014): 17182-7.
description	4.	Wong, G. "Post-exposure therapy of filovirus infections." Trends in Microbiology 22.8 (2014): 456-463.
description	5.	Liu, Jennifer M. "Development of RNA aptamers targeting Ebola virus VP35." Biochemistry 52.47 (2013): 8406-19.
description	6.	Robeson, L. "The upper bound revisited." Journal of membrane science 320.1-2 (2008): 390-400.
description	7.	Freeman, Benny D. "Basis of permeability/selectivity tradeoff relations in polymeric gas separation membranes." Macromolecules 32.2 (1999): 375-380.
description	8.	Robeson, L. M. "High performance polymers for membrane separation." Polymer 35.23 (1994): 4970-4978.
description	9.	STERN, S. "POLYMERS FOR GAS SEPARATIONS - THE NEXT DECADE." Journal of membrane science 94.1-3 (1994): 1-65.
description	10.	Qiu, X. "Antibody therapy for Ebola: is the tide turning around?" Human vaccines & immunotherapeutics (2014): 964-7.
description	11.	Geisbert, Thomas W. "Recombinant vesicular stomatitis virus-based vaccines against ebola and marburg virus infections." The Journal of infectious diseases 204.3 (2011): 1075-81.
description	12.	Takada, A. "A system for functional analysis of Ebola virus glycoprotein." Proceedings of the National Academy of Sciences of the United States of America 94.26 (1997): 14764-14769.
description	13.	Galson, Jacob D. "In-Depth Assessment of Within-Individual and Inter-Individual Variation in the B Cell Receptor Repertoire." Frontiers in immunology 6 (2015): 531-.
description	14.	Carette, Jan E. "Ebola virus entry requires the cholesterol transporter Niemann-Pick C1." Nature 477.7364 (2011): 340-343.
description	15.	Mohamadzadeh, M. "How Ebola and Marburg viruses battle the immune system." Nature reviews. Immunology 7.7: 556-67.
description	16.	Galson, Jacob D. "Analysis of B Cell Repertoire Dynamics Following Hepatitis B Vaccination in Humans, and Enrichment of Vaccine-specific Antibody Sequences." EBioMedicine 2.12 (2015): 2070-9.
description	17.	Woodbine, L. "The clinical impact of deficiency in DNA non-homologous end-joining." DNA repair 16.1 (2014): 84-96.
description	18.	Dekosky, Brandon J. "High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire." Nature biotechnology 31.2 (2013): 166-169.
description	19.	Takada, A. "Identification of protective epitopes on ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses." Journal of virology 77.2 (2003): 1069-74.
description	20.	Bjorndal, Laszlo S. "Ebola virus infection inversely correlates with the overall expression levels of promyelocytic leukaemia (PML) protein in cultured cells." BMC microbiology 3 (2003): 6-.